KA
Kristin Abate sold $450 of KPTI stock
Kristin Abate, Chief Accounting Officer of Karyopharm Therapeutics Inc. (KPTI), sold 378 shares of KPTI stock worth $450, per an SEC Form 4 filed Oct 2, 2026.
It was an open-market sale.
The trade happened on Oct 1, 2026, 1 day before it was made public.
- Traded
- Oct 1, 2026
- Disclosed
- Oct 2, 2026
- Filing delay
- 1 day
- Role
- Chief Accounting Officer
- Source
- SEC Form 4